Skip to main content
. 2019 Nov 21;9(12):2149–2158. doi: 10.1002/2211-5463.12753

Figure 2.

Figure 2

Plasma EV miRNA expression signature for LUAD diagnosis in the training phase. (A‐G) The expression of miR‐451a, miR‐194‐5p, miR‐486‐5p, miR‐411‐5p, miR‐495‐3p, miR‐16‐3p, and miR‐486‐3p in plasma EVs from patients with LUAD (N = 45) and normal samples from healthy volunteers (N = 45) by qRT‐PCR. Each point represents the mean of triplicate samples. Each P‐value was calculated with a nonparametric Mann–Whitney test. ***P < 0.001. NS: no significant difference.